Insider trading

Period: 120 months Stock: CHRS + Add filter Clear all
Views & alerts

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

88 decisions over 120 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

88 decisions over 120 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

88 decisions over 120 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

88 decisions over 120 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
88 decisions over 120 months
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
88 decisions over 120 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

88 decisions over 120 months
Stock
Insider
Type ?
Why it stands out
18 Sep 2019
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$64.56K 3,159 at 20.44
27.1%
16 Sep 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$50.08K 2,500 at 20.03
11.5%
21 Aug 2019
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated 2×
$137.15K 6,318 at 21.71
42.6%
19 Aug 2019
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$57.12K 3,000 at 19.04
26.1%
14 Aug 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$47.50K 2,500 at 19.00
11.5%
15 Jul 2019
Anicetti Vincent R Chief Operating Officer
Sold, plan not stated
$48.00K 2,500 at 19.20
11.5%
2 Jul 2019
HEALY JAMES Director · indirect
Sold, plan not stated
$3.62M 160,000 at 22.61
7.6%
28 Jun 2019
HEALY JAMES Director · indirect
Sold, plan not stated
$4.41M 200,000 at 22.05
8.7%
20 Jun 2019
HEALY JAMES Director · indirect
Sold, plan not stated
$6.78M 317,130 at 21.37
12.1%
19 Jun 2019
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated 3×
$77.59K 3,826 at 20.28
24.9%
18 Jun 2019
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$57.93K 3,000 at 19.31
19.8%
30 May 2019
Lanfear Dennis M President & CEO · indirect
Sold, plan not stated
$631.28K 32,398 at 19.49
2.5%
22 May 2019
HEALY JAMES Director · indirect
Sold, plan not stated
$5.34M 257,870 at 20.69
9.0%
20 Mar 2019
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$44.76K 3,000 at 14.92
18.5%
10 Sep 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$32.70K 1,760 at 18.58
4.5%
29 Aug 2018
HEALY JAMES Director · indirect
Sold, plan not stated
$512.50K 25,000 at 20.50
0.9%
13 Aug 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$33.48K 1,760 at 19.02
4.5%
23 Jul 2018
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$172.47K 9,291 at 18.56
71.1%
Sold half or more
10 Jul 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$18.90K 1,260 at 15.00
3.3%
9 Jul 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$7.52K 500 at 15.03
1.3%
18 Jun 2018
FINCK BARBARA K Chief Medical Officer
Sold, plan not stated
$26.40K 1,760 at 15.00
4.5%
16 May 2018
Lanfear Dennis M See Remarks · indirect
Sold, plan not stated
$341.26K 20,984 at 16.26
1.6%
8 Aug 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$263.30K 17,535 at 15.02
26.1%
5 Jul 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$9.00K 600 at 15.00
0.9%
1 Jun 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated 2×
$230.29K 11,333 at 20.32
14.3%
1 May 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$226.63K 11,333 at 20.00
12.5%
3 Apr 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$234.99K 11,333 at 20.73
11.1%
1 Mar 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$274.17K 11,333 at 24.19
10.0%
1 Feb 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$310.15K 11,333 at 27.37
9.1%
25 Jan 2017
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$105.30K 3,900 at 27.00
56.6%
Sold half or more
3 Jan 2017
Herman Alan C. Chief Scientific Officer
Sold, plan not stated 2×
$316.72K 11,333 at 27.95
8.3%
16 Dec 2016
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$110.36K 3,900 at 28.30
62.7%
Sold half or more
8 Dec 2016
Wahlstrom Mats Director · indirect
Sold, plan not stated
$1.27M 46,190 at 27.52
100%
Sold half or more
7 Dec 2016
Wahlstrom Mats Director · indirect
Sold, plan not stated
$203.33K 7,393 at 27.50
13.8%
1 Dec 2016
Herman Alan C. Chief Scientific Officer
Sold, plan not stated 2×
$310.52K 11,333 at 27.40
7.7%
18 Nov 2016
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$109.96K 3,900 at 28.19
62.7%
Sold half or more
1 Nov 2016
Herman Alan C. Chief Scientific Officer
Sold, plan not stated
$312.04K 11,333 at 27.53
7.2%
21 Oct 2016
Viret Jean-Frederic Chief Financial Officer
Sold, plan not stated
$119.40K 3,900 at 30.62
62.7%
Sold half or more
Showing 51–88 of 88. ← Newer Page 2 of 2